Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001116679-07-000450
Filing Date
2007-02-15
Accepted
2007-02-14 18:03:21
Documents
3
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 JUNE 30, 2007 bio10ka.txt 10-K/A 6676
2 EX. 31.1: 302 CERT OF CEO ex31-1.txt EX-31 4875
3 EX. 31.2: 302 CERT OF PRINCIPAL F&AO ex31-2.txt EX-31 4923
  Complete submission text file 0001116679-07-000450.txt   17990
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Filer) CIK: 0001028205 (see all company filings)

EIN.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-31787 | Film No.: 07623827
SIC: 2834 Pharmaceutical Preparations